Skip to main content

Advertisement

SpringerLink
Log in

Safety and feasibility of intravenous rt-PA in the Emergency Department without a neurologist-based stroke unit: an observational study

  • EM - ORIGINAL
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

Abstract

Early intravenous thrombolysis has proven to be a safe and effective therapy for selected patients with acute ischemic stroke (AIS). Nowadays, thrombolysis is usually delivered by neurologists in “hub” referral centers. However, only a few among eligible patients actually receive treatment. Barriers to early administration of thrombolysis are represented by delays in presentation to referral centers, in-hospital and transfer delays, as well as changes in symptoms during assessment time. The aim of this study is to evaluate the safety and rate of thrombolysis provided in Emergency Department (ED) of a district hospital without neurological stroke team. Consecutive patients with AIS treated with intravenous thrombolysis were prospectively enrolled in this observational study, conducted between May 2010 and December 2013. The main outcomes evaluated were: mortality, symptomatic intracerebral hemorrhage (ICH), systemic adverse events, and neurological recovery. Secondly, all patients admitted with ischemic stroke were retrospectively screened to assess the reasons for exclusion to treatment and the rate of thrombolysis delivered. During the study period, 43 patients with AIS received intravenous rt-PA treatment. The mortality rate at three months was 9.5 % (4/43; 95 % CI 2.6–22.1) and total ICH at any-time CT scan imaging was 18.6 % (8/43; 8.4–33.4). At seven days or at discharge, 35/43 patients (81.4 %; 66.6–91.6) presented a neurological improvement and 46.5 % (20/43; 31.2–62.3) a complete neurological recovery presenting a normal NIHSS, while 9.5 % of patients remained in steady conditions and other 9.5 % worsened (4/43; 2.6–22.1). Outcomes do not appear to be very different from those reported in SITS-MOST study cohort. Among the overall 732 patients with AIS, 117 (16.0 %; 13.4–18.8) were eligible for age and arrived within the three-hour window of time, and the thrombolysis rate was 5.9 % (43/732; 4.3–7.8). Administration of rt-PA in an ED setting without neurological specialized stroke unit seems to be feasible and safe after adequate training. Thrombolysis rate found seems to be favorably comparable with the national average in specialist stroke units. If such data were confirmed by studies of greater dimension, this may imply the ability to perform thrombolysis even in smaller centers without the neurologist, thus being able to treat a greater number of patients in the times proven effective for thrombolysis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Roger VL, Go AS, Lloyd-Jones DM et al (2012) Heart disease and stroke statistics–2012 update: a report from the American Heart Association. Circulation 125:e2–e220

    Article  PubMed  Google Scholar 

  2. Nichols M, Townsend N, Scarborough P, Rayner M (2013) Cardiovasculare disease in Europe: epidemiological update. Eur Heart J. doi:10.1093/eurheartj/eht356

    PubMed Central  Google Scholar 

  3. Truelsen T, Piechowski-J B et al (2006) Stroke incidence and prevalence in Europe: a review of available data. Eur J Neurol 13:581–598

    Article  CAS  PubMed  Google Scholar 

  4. The National Institute of Neurological Disorders and Stroke rt-PA Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Eng J Med 333(24):1581–1587

    Article  Google Scholar 

  5. Wahlgren N, Ahmed N, SITS-MOST investigators et al (2007) Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke- Monitoring Study (SITS-MOST): an observational study. Lancet 369:275–282

    Article  CAS  PubMed  Google Scholar 

  6. Sandercock P, the IST-3 collaborative group (2102) The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomized controlled trial. Lancet 379:2352–2363

    Article  PubMed  Google Scholar 

  7. Wardlaw JM, Murray V, Berge E et al (2012) Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet 379:2364–2372

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Costantino G, Podda GM, Bonzi M, Sbrojavacca R (2013) Italian guidelines on thrombolysis indications in ischemic stroke have been revised after IST-3 trial and Cochrane revision: cons. Intern Emerg Med 8:651–652

    Article  PubMed  Google Scholar 

  9. Gensini GF, Zaninelli A, Ricci S, Gandolfo C, Cerrato P, Sterzi R, Toni D, et al (2012) Stroke Prevention and Educational Awareness Diffusion (SPREAD). Italian Guidelines. VII Edition. Pierrel Research Pub. (www.spread.it)

  10. Jauch EC, Saver JL, Adams HP, Bruno A, Connors JJ, AHA/ASA Guideline et al (2013) Guidelines for early management of patients with acute ischemic stroke. Stroke 44:870–947

    Article  PubMed  Google Scholar 

  11. Lees KR, Bluhmki E, von Kummer R et al (2010) Time to treatment with intravenous alteplase and outcome in stroke: an update pooled analysis of ECASS, ATLANTIS, NINDS and EPITHET trials. Lancet 375:1695–1703

    Article  CAS  PubMed  Google Scholar 

  12. Kleindorfer D, La Rosa FR, Khatri P et al (2013) Temporal trends in acute stroke management. Stroke 44(S1):S129–S131

    Article  PubMed  Google Scholar 

  13. Kleindorfer D, Xu Y, Moomaw CJ, Khatri P et al (2009) US geographic distribution of rt-pa utilization by hospital for acute ischemic stroke. Stroke 40:3580–3584

    Article  PubMed  Google Scholar 

  14. Rudd AG, Hoffman A, Grant R, Campbell JT, Lowe D (2011) Stroke thrombolysis in England, wales and Northern Ireland: how much do we do and how much do we need? J Neurol Neurosurg Psychiatry 82:14–19

    Article  CAS  PubMed  Google Scholar 

  15. Guidetti D, Spallazzi M, Toni D, Rota E et al (2013) Updating on Italian stroke units: the “CCM study”. Neurol Sci 34:1087–1092

    Article  CAS  PubMed  Google Scholar 

  16. Faiz KW, Sundseth A, Thomessen B et al (2013) Prehospital delay in acute stroke and TIA. Emerg Med J 30:669–674

    Article  PubMed  Google Scholar 

  17. Evenson KR, Foraker A, Morris DL, Rosamond WD (2009) A comprehensive review of prehospital and in-hospital delay times in acute stroke care. Int J Stroke 4(3):187–199

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Barber PA, Zhang J, Demchuk AM et al (2001) Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 56:1015–1020

    Article  CAS  PubMed  Google Scholar 

  19. Cocho D, Belvis R, Martì-Fabregas J, Molina-Porcel L et al (2005) Reasons for exclusion from thrombolytic therapy following acute ischemic stroke. Neurology 64:719–720

    Article  CAS  PubMed  Google Scholar 

  20. Prabhakaran S, Ward E, John S, Lopes DK et al (2011) Transfer delay is a major factor limiting the use of intra-arterial treatment in acute ischemic stroke. Stroke 42:1626–1630

    Article  CAS  PubMed  Google Scholar 

  21. Volan AP (2012) An analysis of outcome of emergency physician/department-based thrombolysis for stroke. Emerg Med J 29:640–643

    Article  Google Scholar 

  22. Scott PA, Frederiksen SM, Kalbfleisch JD, Xu Z, Meurer WJ et al (2010) Safety of intravenous thrombolytic use in four emergency departments without acute stroke teams. Acad Emerg Med 17(10):1062–1071

    Article  PubMed Central  PubMed  Google Scholar 

  23. Semplicini A, Benetton V, Macchini L, Realdi A et al (2008) Intravenous thrombolysis in the emergency department for the treatment of acute ischaemic stroke. Emerg Med J 25:403–406

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  24. Katzan IL, Hamer MD, Hixson ED, Furlan AJ, Abou-chebl A et al (2004) Utilization of intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol 61:346–350

    Article  PubMed  Google Scholar 

  25. Wiegand N, Luthy R, Vogel B, Straumann E, Beynon C et al (2004) Intravenous thrombolysis for ischaemic stroke is also safe and efficient without a specialised neuro-intensive care unit. Swiss Med Wkly 134:14–17

    PubMed  Google Scholar 

  26. Warwick Pexman JH, Barber PA, Hill MD et al (2001) Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scan in patients with acute stroke. Am J Neuroradiol 22:1534–1542

    Google Scholar 

  27. Adams HP, Bendixen BH, Kappelle LJ et al (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Stroke 24(1):35–41

    Article  PubMed  Google Scholar 

  28. Bamford J, Sandercock P, Dennis M et al (1991) Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337:1521–1526

    Article  CAS  PubMed  Google Scholar 

  29. Larrue V, von Kummer RR et al (2001) Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke 32:438–441

    Article  CAS  PubMed  Google Scholar 

  30. Berger C, Fiorelli M, Steiner T et al (2001) Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke 32:1330–1335

    Article  CAS  PubMed  Google Scholar 

  31. Smith EE, Abdullah AR et al (2005) Poor outcomes in patients who do not receive intravenous tPA because of mild or improving ischemic stroke. Stroke 36:2497–2499

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Emergency Department, Ospedale Civile Santa Maria della Scaletta. Imola, Via Montericco 4, Imola (Bologna), 40026, Italy

    Andrea Tampieri, Eugenio Giovannini, Anna Maria Rusconi, Lorenzo Cristoni, Daniela Bendanti, Patrizia Cenni & Tiziano Lenzi

Authors
  1. Andrea Tampieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eugenio Giovannini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anna Maria Rusconi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lorenzo Cristoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Daniela Bendanti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Patrizia Cenni
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tiziano Lenzi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrea Tampieri.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tampieri, A., Giovannini, E., Rusconi, A.M. et al. Safety and feasibility of intravenous rt-PA in the Emergency Department without a neurologist-based stroke unit: an observational study. Intern Emerg Med 10, 181–192 (2015). https://doi.org/10.1007/s11739-014-1153-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-014-1153-9

Keywords

Search

Navigation